CY-301

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCY-301
Drug Alias NameHSV therapeutic (CytoGenix)anti-HSV DNA formulation (CytoGenix)CYGpssXE-59SimplivirpssXV(59) +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytoGenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytoGenix Inc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A